Docosahexaenoic Acid–Derived Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) With Anti-inflammatory Properties

0462569 - FGÚ 2017 RIV US eng J - Journal Article
Kuda, Ondřej - Březinová, Marie - Rombaldová, Martina - Slavíková, Barbora - Pošta, Martin - Beier, Petr - Janovská, Petra - Veleba, J. - Kopecký Jr., J. - Kudová, Eva - Pelikánová, T. - Kopecký, Jan
Docosahexaenoic Acid–Derived Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) With Anti-inflammatory Properties.
Diabetes. Roč. 65, č. 9 (2016), s. 2580-2590. ISSN 0012-1797. E-ISSN 1939-327X
R&D Projects: GA MŠMT(CZ) LH14040; GA ČR(CZ) GB14-36804G
Institutional support: RVO:67985823 ; RVO:61388963
Keywords : FAHFA * n-3 PUFA * white adipose tissue * lipokine
Subject RIV: FB - Endocrinology, Diabetology, Metabolism, Nutrition
Impact factor: 8.684, year: 2016

White adipose tissue (WAT) is a complex organ with both metabolic and endocrine functions. Dysregulation of all of these functions of WAT, together with low-grade inflammation of the tissue in obese individuals, contributes to the development of insulin resistance and type 2 diabetes. n-3 polyunsaturated fatty acids (PUFAs) of marine origin play an important role in the resolution of inflammation and exert beneficial metabolic effects. Using experiments in mice and overweight/obese patients with type 2 diabetes, we elucidated the structures of novel members of fatty acid esters of hydroxy fatty acids—lipokines derived from docosahexaenoic acid (DHA) and linoleic acid, which were present in serum and WAT after n-3 PUFA supplementation. These compounds contained DHA esterified to 9- and 13-hydroxyoctadecadienoic acid (HLA) or 14-hydroxydocosahexaenoic acid (HDHA), termed 9-DHAHLA, 13-DHAHLA, and 14-DHAHDHA, and were synthesized by adipocytes at concentrations comparable to those of protectins and resolvins derived from DHA in WAT. 13-DHAHLA exerted anti-inflammatory and proresolving properties while reducing macrophage activation by lipopolysaccharides and enhancing the phagocytosis of zymosan particles. Our results document the existence of novel lipid mediators, which are involved in the beneficial anti-inflammatory effects attributed to n-3 PUFAs, in both mice and humans.
Permanent Link: http://hdl.handle.net/11104/0261999